
XTL Biopharmaceuticals Ltd. XTLB
$ 0.8
4.35%
Annual report 2024
added 02-21-2026
XTL Biopharmaceuticals Ltd. Operating Cycle 2011-2026 | XTLB
Annual Operating Cycle XTL Biopharmaceuticals Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | 214 | 269 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 269 | 214 | 242 |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Apellis Pharmaceuticals
APLS
|
115 | $ 20.36 | -1.64 % | $ 2.57 B | ||
|
Aptorum Group Limited
APM
|
4.89 | $ 0.81 | -3.83 % | $ 4.42 M | ||
|
Axsome Therapeutics
AXSM
|
273 | $ 164.62 | -1.06 % | $ 8.19 B | ||
|
AbCellera Biologics
ABCL
|
173 | $ 3.74 | -2.23 % | $ 1.12 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M | ||
|
Certara
CERT
|
89.6 | $ 7.27 | 3.05 % | $ 1.17 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
178 | $ 23.94 | 0.23 % | $ 2.93 B | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Eton Pharmaceuticals
ETON
|
55.7 | $ 17.89 | -1.43 % | $ 459 M | ||
|
Exelixis
EXEL
|
140 | $ 40.99 | -0.1 % | $ 11.1 B | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Acorda Therapeutics
ACOR
|
394 | - | -24.86 % | $ 820 K | ||
|
Galapagos NV
GLPG
|
149 | $ 33.2 | -2.61 % | $ 2.69 B | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Codexis
CDXS
|
50.2 | $ 1.0 | -1.47 % | $ 73.4 M | ||
|
Halozyme Therapeutics
HALO
|
347 | $ 69.4 | -0.64 % | $ 8.32 B | ||
|
Aeterna Zentaris
AEZS
|
115 | - | 5.93 % | $ 314 M | ||
|
Harmony Biosciences Holdings
HRMY
|
49.3 | $ 28.63 | -0.95 % | $ 1.65 B | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
ImmuCell Corporation
ICCC
|
188 | $ 6.3 | -3.67 % | $ 51.5 M | ||
|
Immuron Limited
IMRN
|
1.46 K | $ 0.75 | -0.69 % | $ 6.46 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
4.13 | $ 3.24 | -3.14 % | $ 1.16 M | ||
|
Inhibrx
INBX
|
31.1 | $ 76.35 | -1.47 % | $ 3.6 B | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
InMed Pharmaceuticals
INM
|
313 | $ 0.78 | -4.88 % | $ 1.91 M | ||
|
Insmed Incorporated
INSM
|
400 | $ 147.23 | 0.62 % | $ 29.3 B |